SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-27
👔
C4 Therapeutics, Inc.
@CCCC_InsiderForm 4 Filing: Hoerter Steven L. Acquires (Grant) shares of $CCCC
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
C4 Therapeutics, Inc.
Ticker: $CCCC
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-24
Shares: 62,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Hoerter Steven L., holds the title of Director at C4 Therapeutics, Inc..
On 2026-06-24, the insider transacted 62,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Hoerter Steven L. (Director) was granted $0 of $CCCC
Post-Transaction Position: 62,000 shares
SEC Accession No: 0001470831-26-000670 (CIK: 1533451)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.